| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8605338 | The Journal of Pain | 2017 | 33 Pages |
Abstract
This article highlights common metrics for evaluating the clinical utility of screening tests in predicting aberrant opioid use. In addition, it explores a series of considerations key to developing clinical guidelines for interpreting the results of screeners in this context.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Robert W. Bailey, Kevin E. Vowles,